Dr. Paul R. Ponnaiya, MD

Dr. Ponnaiya practices at Encompass Health Rehabilitation Hospital of Rock Hill in Rock Hill, South Carolina, part of Encompass Health.

Dr. Ponnaiya's NPI, 1528059672, was assigned on October 28, 2005. Dr. Ponnaiya holds Nevada license 10806.

Dr. Ponnaiya's primary practice is Encompass Health Rehabilitation Hospital of Rock Hill, at 1795 Frank Gaston Blvd, Rock Hill, SC 29732 in York County. The practice phone is (803) 326-3500.

Dr. Ponnaiya's primary practice is Encompass Health Rehabilitation Hospital of Rock Hill in Rock Hill, South Carolina, part of Encompass Health. Dr. Ponnaiya is also affiliated with Rock Hill Hospital - Piedmont Medical Network. The medical group on file is Shiranee M Jayasooriya MD. Dmand AI also links Dr. Ponnaiya to 4 more hospitals, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ponnaiya practices, 8 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Ponnaiya's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Ponnaiya is licensed in Nevada.

CMS data shows 5,622 Medicare services from Dr. Ponnaiya across 3 procedure codes in 2024, for 572 Medicare patients. Medicare paid $375,642 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 572 Medicare patients who saw Dr. Ponnaiya in 2024. The largest group is 75 to 84, with 266 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 2.28, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ponnaiya's median patient age at 74, with 50% women.

In 2024, Dr. Ponnaiya wrote 1,620 Medicare Part D claims for 357 patients. 87% of them were for generic drugs. CMS names the drug for 1,207 of them, across 39 drugs with 11 or more claims each, at $62,033 in total drug cost. In 2023, CMS named 994 claims across 36 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Ponnaiya for performance year 2024, reported individually. Dr. Ponnaiya accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 4 general payments to Dr. Ponnaiya from 2 drug and device companies from 2021 to 2024. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $52.